Pharmacy500 Marketplace

Contract Manufacturing, Drug Shortage Mitigation

Leaders in Contract Manufacturing, Drug Shortage Mitigation...

Aisle OVERVIEW

Drug Shortage Mitigation refers to the strategies and processes implemented by healthcare providers, pharmacies, manufacturers, and regulatory agencies to prevent, manage, and alleviate the impact of drug shortages on patient care. A drug shortage occurs when the demand for a specific medication exceeds the supply, or when there are disruptions in manufacturing, distribution, or other factors that hinder the availability of the drug. Mitigation efforts focus on maintaining access to essential medications and minimizing the effects on treatment outcomes.

Effective mitigation strategies require a combination of proactive planning, alternative medication options, collaboration with regulatory agencies, and clear communication with healthcare providers and patients. By implementing these strategies, pharmacies and healthcare systems can minimize the impact of drug shortages and ensure that patient care is not compromised.

Company Profiles

Pharmacy500

Request information from Pharmacy500

Subscribe

The Pharmacy500 is awarded to 500 pharmacy supply chain businesses and associations that significantly impacted dispensing pharmacies in the U.S. over the past year.

Pharmacy500 Benefits

The following are complimentary benefits extended to Pharmacy500 companies and associations (coming this spring!)

  1. Company listings in the Platinum Pages Buyer’s Guide, 20Ways publications, and RXinsider website
  2. Company inclusion in the 20Ways themed Buyer’s Guide
  3. Unlimited job postings in the Pharmacy500 Career Center *Unlimited through 2025
  4. Tradeshow promotional resources including Pharmacy500 floor stickers and lanyards
  5. Two posts (annually) in RXinsider’s Pharmacy Market BUZZ news feed

Who are the Pharmacy500 and what are the selection criteria?

The Pharmacy500 includes:

  1. Companies within the Pharmacy Supply Chain
  2. National Pharmacy Trade Associations

The Pharmacy500 Selection Committee applies the following criteria to determine the list of 500:

  • Offers and actively markets at least one product or service to dispensing pharmacies
  • Dispensing pharmacies comprise at least 25% of their customer base
  • Has an estimated annual revenue exceeding $500,000
  • Has five or more full-time employees, and has been in business for more than two years
  • Has a national presence
  • Exhibited at one of the following national conferences in the previous year: APhA; ASCP Annual Meeting & Exhibition; Asembia’s Summit; ASHP Midyear Clinical Meetings & Exhibition; Cardinal Health RBC; McKesson ideaShare; NACDS Total Store Expo; NASP Annual Meeting & Expo; NCPA Annual Convention and Expo; Pharmacy Futures (ASHP Summer); ThoughtSpot.

The following supply chain segments are critical to pharmacy operations and patient care, but are excluded from the Pharmacy500 simply due to volume:

  • Manufacturers and Merchandisers of Pharmaceuticals
  • Manufacturers and Merchandisers of Devices and OTC Products
  • Colleges of Pharmacy
  • State Associations
  • Government Agencies and State Boards of Pharmacy
  • Pharmacy Fraternities & Sororities
  • Dispensing Pharmacies, Health Systems, Chains, Payors, and PBMs

Product Highlight SHOWCASE

Subject Matter Expert & Thought Leader PROFILES

Resources & Awareness

This visual represents the comprehensive structure of the modern pharmacy landscape, capturing the interconnected roles, settings, specializations, and operational elements that support patient care and drug distribution. Developed by RXinsider, the ecosystem map is designed to serve as a foundational reference for education, training, communication, and strategic planning across the pharmacy industry.

RXinsider’s Pharmacy500 Stock ETF is a stock portfolio comprised of the largest publicly traded companies in the Pharmacy500.

This report offers a concise snapshot of the Pharmacy500 companies by highlighting new company additions, and examining regional distributions, practice settings, supply chain categories, and the key conferences attended.

Pharmacy500

AIS Healthcare
Amneal Pharmaceuticals LLC
Azurity Pharmaceuticals, Inc.
B. Braun Medical Inc.
Baxter
Beutlich Pharmaceuticals LLC
Central Admixture Pharmacy Services, Inc. (CAPS)
Cipla, Inc.
Civica
Dr.Reddy’s Laboratories Ltd.
Endo USA
Fagron
Fresenius Kabi Group
Germfree
Grifols
Hikma Pharmaceuticals
Leiters Health
Lupin Pharmaceuticals Inc.
Medivant Healthcare
Moderna, Inc.
Nephron Pharmaceuticals Corporation
OurPharma LLC
Pine Pharmaceuticals
Precision Dose, Inc.
QuVa Pharma
Revelation Pharma
SCA Pharma
STAQ Pharma, Inc.
Turbare Manufacturing, LLC
Wells Pharma
West Pharmaceutical Services, Inc.

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Contract Manufacturing, Drug Shortage Mitigation

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe